Open Day 1 of ESOC 2025 in Helsinki: OPTIMIST Trial Highlights
European Stroke Organisation (ESO) has shared an insightful post on X:
”Missed it live? Revisit Day 1 PI insights from ESOC 2025 in Helsinki. Investigators, moderated by Jelle De Meester and Teresa Ullberg, discuss the OPTIMIST main trial – nearly 5,000 patients, 114 hospitals, 8 countries.”
Watch the footage here.
Day 1 of ESOC 2025 in Helsinki featured key insights from the highly anticipated OPTIMIST main trial.
The trial was presented by principal investigators and moderated by Jelle De Meester and Teresa Ullberg.
The large-scale trial enrolled nearly 5,000 patients across 114 hospitals in 8 countries, offering robust data on stroke care optimization.
For those who missed the live session, the discussion provided critical updates on trial methodology, patient outcomes, and future directions in acute stroke management.
A must-watch for clinicians and researchers shaping the next generation of stroke care!
Hemostasis Today, your daily source of latest news on stroke management.
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription